Intrinsiqs

Is Akebia Therapeutics, Inc. overvalued?

Akebia Therapeutics, Inc. (AKBA) — key valuation metrics and fundamentals.

No verdict
Price
$0.87
Fair value
Current P/E
Normal P/E
Market cap
$234.1M
Dividend yield
0.0%
Return on equity
-93.7%
Sector
Healthcare

See the full interactive analysis →

Fair value compares AKBA's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Aug 2026.